Ron Bentsur - 25 Nov 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
25 Nov 2022
Net transactions value
+$3,334
Form type
4
Filing time
29 Nov 2022, 15:31:03 UTC
Previous filing
21 Nov 2022
Next filing
30 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,107 +150 +0% $7.38 3,015,009 25 Nov 2022 Direct F1
transaction NVCT Common Stock Purchase $1,110 +150 +0% $7.40 3,015,159 28 Nov 2022 Direct F1
transaction NVCT Common Stock Purchase $1,118 +150 +0% $7.45 3,015,309 29 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.